| Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche Cancer Cell, 2016 | 162 | 2016 |
| Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube? DM Klotz, P Wimberger Archives of gynecology and obstetrics 296, 1055-1062, 2017 | 78 | 2017 |
| Inhibition of P-glycoprotein at the blood–brain barrier by phytochemicals derived from traditional Chinese medicine A Mahringer, S Karamustafa, D Klotz, S Kahl, VB Konkimalla, Y Wang, ... Cancer Genomics & Proteomics 7 (4), 191-205, 2010 | 47 | 2010 |
| Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies? DM Klotz, P Wimberger Archives of Gynecology and Obstetrics 302, 1087-1102, 2020 | 41 | 2020 |
| The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively DM Klotz, SA Nelson, K Kroboth, IP Newton, S Radulescu, RA Ridgway, ... Journal of cell science 125 (4), 887-895, 2012 | 31 | 2012 |
| The adenomatous polyposis coli protein contributes to normal compaction of mitotic chromatin D Dikovskaya, G Khoudoli, IP Newton, GS Chadha, D Klotz, ... PloS one 7 (6), e38102, 2012 | 20 | 2012 |
| Toward operative in vivo fluorescence imaging of the c‐M et proto‐oncogene for personalization of therapy in ovarian cancer S Liu, Y Zheng, D Volpi, M El‐Kasti, D Klotz, I Tullis, A Henricks, L Campo, ... Cancer 121 (2), 202-213, 2015 | 18 | 2015 |
| Prognostic relevance of longitudinal HGF levels in serum of patients with ovarian cancer DM Klotz, T Link, P Wimberger, JD Kuhlmann Molecular oncology 15 (12), 3626-3638, 2021 | 8 | 2021 |
| The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs.-resistant ovarian cancer cells in vitro S Schott, P Wimberger, B Klink, K Gruetzmann, J Puppe, US Wauer, ... Oncotarget 8 (44), 76935, 2017 | 8 | 2017 |
| Low mood, visual hallucinations, and falls–heralding the onset of rapidly progressive probable sporadic Creutzfeldt–Jakob disease in a 73-year old: a case report DM Klotz, RS Penfold Journal of medical case reports 12, 1-5, 2018 | 6 | 2018 |
| The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker DM Klotz, T Link, M Goeckenjan, P Wimberger, JD Kuhlmann Molecular Oncology 15 (9), 2491-2503, 2021 | 5 | 2021 |
| The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib C Wichmann, DM Klotz, HJ Zeiler, RA Hilger, K Grützmann, A Krüger, ... Gynecologic Oncology 159 (3), 850-859, 2020 | 5 | 2020 |
| Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients DM Klotz, T Link, M Goeckenjan, P Wimberger, AR Poetsch, N Jaschke, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (1), 109-117, 2022 | 4 | 2022 |
| Colorectal cancer stem cells and their implications for novel anticancer therapy D Klotz Expert review of anticancer therapy 13 (4), 461-468, 2013 | 4 | 2013 |
| Clinical impact of soluble neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis DM Klotz, JD Kuhlmann, T Link, M Goeckenjan, LC Hofbauer, A Göbel, ... Frontiers in Oncology 12, 974885, 2022 | 2 | 2022 |
| Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer DM Klotz, FM Schwarz, A Dubrovska, K Schuster, M Theis, A Krüger, ... Cancers 15 (15), 3774, 2023 | 1 | 2023 |
| High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer A Göbel, TD Rachner, O Hoffmann, DM Klotz, S Kasimir-Bauer, R Kimmig, ... Archives of Gynecology and Obstetrics, 1-10, 2024 | | 2024 |
| A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin) DM Klotz, T Link, P Wimberger, JD Kuhlmann Clinical Chemistry and Laboratory Medicine (CCLM) 62 (3), 530-539, 2024 | | 2024 |
| Hepatocyte growth factor (HGF) im Urin als prognostischer Biomarker bei Patientinnen mit Ovarialkarzinom S Locke, DM Klotz, T Link, JD Kuhlmann, P Wimberger Geburtshilfe und Frauenheilkunde 83 (06), 62, 2023 | | 2023 |
| DKK1 als blutbasierter prognostischer Biomarker bei Patientinnen mit Ovarialkarzinom DM Klotz, T Link, M Goeckenjan, P Wimberger, AR Poetsch, N Jaschke, ... Geburtshilfe und Frauenheilkunde 82 (06), 58, 2022 | | 2022 |
